Back to search
COVID-19-Induced Parosmia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which COVID-19-Induced Parosmia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which COVID-19-Induced Parosmia trials you may qualify forChronic olfactory dysfunction, both hyposmia and parosmia, from the COVID-19 pandemic is a growing public health crisis, affecting up to 1.2 million people in t…
Aim: The aim is to investigate the effect of olfactory training with essential oils versus olfactory training with placebo-oils in patients with COVID-19 induce…
Chronic olfactory dysfunction from the COVID-19 pandemic is a growing public health crisis with up to 1.2 million people in the Unites States affected. Olfactor…
Chronic olfactory dysfunction, both hyposmia and parosmia, from the COVID-19 pandemic is a growing public health crisis with up to 1.2 million people in the Uni…